Table 1:
No. | % | |
---|---|---|
Total | 72 | 100 |
Median Age, years: 42 | ||
Sex | ||
Male | 46 | 63.9 |
Female | 26 | 36.1 |
Race and Ethnicity | ||
Hispanic Ethnicity of Any Race | 10 | 13.9 |
American Indian or Alaskan native | 3 | 4.2 |
Black or African American | 15 | 20.8 |
White/Caucasian | 43 | 59.7 |
Asian, Native Hawaiian or other | ||
Pacific Islander | 1 | 1.4 |
Multiracial or other | 9 | 12.5 |
Education | ||
Less than high school | 29 | 40.3 |
High school graduate/GED | 28 | 38.9 |
Some College, 4- year graduate or higher | 14 | 19.4 |
Duration of treatment-engagement** | ||
Less than 1 week | 1 | 1.4 |
1 week to 1 month | 3 | 4.2 |
1 to 3 months | 7 | 9.7 |
3 to 6 months | 12 | 16.7 |
6 months to 1 year | 9 | 12.5 |
1 to 2 years | 20 | 27.8 |
More than 2 years | 14 | 19.4 |
Have dropped out and re-entered since start of study | 6 | 8.3 |
No. of MAT treatment episodes (Range 0–6 episodes) | ||
Not yet on MAT | 7 | 9.7 |
First treatment episode | 20 | 27.8 |
Second treatment episode | 22 | 30.6 |
Three or more episodes | 23 | 31.9 |
Description of participants for whom data were available (9 participants were missing relevant administrative data, including 7 participants from Syringe Exchange Program
Includes non-MAT clinical activities.